Literature DB >> 22108860

Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.

Xianmei Meng1, Amanda Neises, Rui-Jun Su, Kimberly J Payne, Linda Ritter, Daila S Gridley, Jun Wang, Matilda Sheng, K-H William Lau, David J Baylink, Xiao-Bing Zhang.   

Abstract

The reprogramming of cord blood (CB) cells into induced pluripotent stem cells (iPSCs) has potential applications in regenerative medicine by converting CB banks into iPSC banks for allogeneic cell replacement therapy. Therefore, further investigation into novel approaches for efficient reprogramming is necessary. Here, we show that the lentiviral expression of OCT4 together with SOX2 (OS) driven by a strong spleen focus-forming virus (SFFV) promoter in a single vector can convert 2% of CB CD34(+) cells into iPSCs without additional reprogramming factors. Reprogramming efficiency was found to be critically dependent upon expression levels of OS. To generate transgene-free iPSCs, we developed an improved episomal vector with a woodchuck post-transcriptional regulatory element (Wpre) that increases transgene expression by 50%. With this vector, we successfully generated transgene-free iPSCs using OS alone. In conclusion, high-level expression of OS alone is sufficient for efficient reprogramming of CB CD34(+) cells into iPSCs. This report is the first to describe the generation of transgene-free iPSCs with the use of OCT4 and SOX2 alone. These findings have important implications for the clinical applications of iPSCs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22108860      PMCID: PMC3277237          DOI: 10.1038/mt.2011.258

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  47 in total

Review 1.  Transcriptional regulation and transformation by Myc proteins.

Authors:  Sovana Adhikary; Martin Eilers
Journal:  Nat Rev Mol Cell Biol       Date:  2005-08       Impact factor: 94.444

Review 2.  SV40 large T antigen targets multiple cellular pathways to elicit cellular transformation.

Authors:  Deepika Ahuja; M Teresa Sáenz-Robles; James M Pipas
Journal:  Oncogene       Date:  2005-11-21       Impact factor: 9.867

Review 3.  Umbilical cord blood banking: an update.

Authors:  Merlin G Butler; Jay E Menitove
Journal:  J Assist Reprod Genet       Date:  2011-05-27       Impact factor: 3.412

4.  Design of HIV vectors for efficient gene delivery into human hematopoietic cells.

Authors:  Priscilla Y Yam; Shulian Li; Jerry Wu; Jun Hu; John A Zaia; Jiing-Kuan Yee
Journal:  Mol Ther       Date:  2002-04       Impact factor: 11.454

5.  High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter.

Authors:  Christophe Demaison; Kathryn Parsley; Gaby Brouns; Michaela Scherr; Karin Battmer; Christine Kinnon; Manuel Grez; Adrian J Thrasher
Journal:  Hum Gene Ther       Date:  2002-05-01       Impact factor: 5.695

6.  Global protein stability profiling in mammalian cells.

Authors:  Hsueh-Chi Sherry Yen; Qikai Xu; Danny M Chou; Zhenming Zhao; Stephen J Elledge
Journal:  Science       Date:  2008-11-07       Impact factor: 47.728

7.  Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

Authors:  Kazutoshi Takahashi; Koji Tanabe; Mari Ohnuki; Megumi Narita; Tomoko Ichisaka; Kiichiro Tomoda; Shinya Yamanaka
Journal:  Cell       Date:  2007-11-30       Impact factor: 41.582

8.  Differential effects of HOXB4 on nonhuman primate short- and long-term repopulating cells.

Authors:  Xiao-Bing Zhang; Brian C Beard; Katherine Beebe; Barry Storer; R Keith Humphries; Hans-Peter Kiem
Journal:  PLoS Med       Date:  2006-05-02       Impact factor: 11.069

9.  Promoter trapping reveals significant differences in integration site selection between MLV and HIV vectors in primary hematopoietic cells.

Authors:  Michele De Palma; Eugenio Montini; Francesca R Santoni de Sio; Fabrizio Benedicenti; Alessandra Gentile; Enzo Medico; Luigi Naldini
Journal:  Blood       Date:  2004-11-12       Impact factor: 22.113

10.  Lentiviral vectors containing an enhancer-less ubiquitously acting chromatin opening element (UCOE) provide highly reproducible and stable transgene expression in hematopoietic cells.

Authors:  Fang Zhang; Susannah I Thornhill; Steven J Howe; Meera Ulaganathan; Axel Schambach; Joanna Sinclair; Christine Kinnon; H Bobby Gaspar; Michael Antoniou; Adrian J Thrasher
Journal:  Blood       Date:  2007-04-24       Impact factor: 22.113

View more
  39 in total

1.  Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.

Authors:  C Bueno; J L Sardina; B Di Stefano; D Romero-Moya; A Muñoz-López; L Ariza; M C Chillón; A Balanzategui; J Castaño; A Herreros; M F Fraga; A Fernández; I Granada; O Quintana-Bustamante; J C Segovia; K Nishimura; M Ohtaka; M Nakanishi; T Graf; P Menendez
Journal:  Leukemia       Date:  2015-10-26       Impact factor: 11.528

Review 2.  Cardiac stem cells for myocardial regeneration: promising but not ready for prime time.

Authors:  Joshua Lader; Maxine Stachel; Lei Bu
Journal:  Curr Opin Biotechnol       Date:  2017-06-04       Impact factor: 9.740

3.  Establishment of human cell type-specific iPS cells with enhanced chondrogenic potential.

Authors:  Rosa M Guzzo; Vanessa Scanlon; Archana Sanjay; Ren-He Xu; Hicham Drissi
Journal:  Stem Cell Rev Rep       Date:  2014-12       Impact factor: 5.739

Review 4.  All roads lead to induced pluripotent stem cells: the technologies of iPSC generation.

Authors:  Kejin Hu
Journal:  Stem Cells Dev       Date:  2014-03-21       Impact factor: 3.272

5.  A facile method to establish human induced pluripotent stem cells from adult blood cells under feeder-free and xeno-free culture conditions: a clinically compliant approach.

Authors:  Bin-Kuan Chou; Haihui Gu; Yongxing Gao; Sarah N Dowey; Ying Wang; Jun Shi; Yanxin Li; Zhaohui Ye; Tao Cheng; Linzhao Cheng
Journal:  Stem Cells Transl Med       Date:  2015-03-05       Impact factor: 6.940

Review 6.  Stem cell manipulation, gene therapy and the risk of cancer stem cell emergence.

Authors:  Flora Clément; Elodie Grockowiak; Florence Zylbersztejn; Gaëlle Fossard; Stéphanie Gobert; Véronique Maguer-Satta
Journal:  Stem Cell Investig       Date:  2017-07-25

7.  The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.

Authors:  Xinxiu Liu; Jiayu Chen; Wenchao Liu; Xiaogang Li; Qi Chen; Tao Liu; Shaorong Gao; Min Deng
Journal:  Neurogenetics       Date:  2015-04-26       Impact factor: 2.660

8.  Neurobiology meets genomic science: the promise of human-induced pluripotent stem cells.

Authors:  Hanna E Stevens; Jessica Mariani; Gianfilippo Coppola; Flora M Vaccarino
Journal:  Dev Psychopathol       Date:  2012-11

9.  Rapid and efficient reprogramming of human fetal and adult blood CD34+ cells into mesenchymal stem cells with a single factor.

Authors:  Xianmei Meng; Rui-Jun Su; David J Baylink; Amanda Neises; Jason B Kiroyan; Wayne Yuk-Wai Lee; Kimberly J Payne; Daila S Gridley; Jun Wang; K-H William Lau; Gang Li; Xiao-Bing Zhang
Journal:  Cell Res       Date:  2013-03-12       Impact factor: 25.617

Review 10.  New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cells.

Authors:  Zita Garate; Brian R Davis; Oscar Quintana-Bustamante; Jose C Segovia
Journal:  Hum Gene Ther       Date:  2013-06       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.